A survey of the role of noncovalent sulfur interactions in drug design

BR Beno, KS Yeung, MD Bartberger… - Journal of medicinal …, 2015 - ACS Publications
… (11h, 22, 38) The electron acceptor capability of the heavier aryl halides (Ar–X with X = Cl,
Br, and I) is proportional to the size and relative magnitude of the σ-hole opposite the C–X …

Synchronous or asynchronous? An “experimental” transition state from a direct comparison of experimental and theoretical kinetic isotope effects for a Diels− Alder …

BR Beno, KN Houk, DA Singleton - Journal of the American …, 1996 - ACS Publications
Theory and experiment agree that the concerted mechanism for the parent Diels-Alder (DA)
reaction is favored by 2-7 kcal/mol over an alternative stepwise diradical pathway. 1 …

The design of combinatorial libraries using properties and 3D pharmacophore fingerprints

BR Beno, JS Mason - Drug Discovery Today, 2001 - Elsevier
… Mason and Beno reported an SA procedure for combinatorial reagent selection that concurrently
optimizes product diversity in a BCUT chemistry space, as well as in terms of four-point …

An antibody exo Diels-Alderase inhibitor complex at 1.95 angstrom resolution

…, JT Yli-Kauhaluoma, C Gao, Q Deng, BR Beno… - Science, 1998 - science.org
A highly specific Diels-Alder protein catalyst was made by manipulating the antibody
repertoire of the immune system. The catalytic antibody 13G5 catalyzes a disfavored exo Diels-…

Discovery and preclinical characterization of the cyclopropylindolobenzazepine BMS-791325, a potent allosteric inhibitor of the hepatitis C virus NS5B polymerase

…, X Zheng, S Chao, JH Sun, BR Beno… - Journal of Medicinal …, 2014 - ACS Publications
Described herein are structure–activity relationship studies that resulted in the optimization
of the activity of members of a class of cyclopropyl-fused indolobenzazepine HCV NS5B …

Epitope and paratope mapping of PD-1/Nivolumab by mass spectrometry-based Hydrogen–deuterium exchange, cross-linking, and molecular docking

MM Zhang, RYC Huang, BR Beno… - Analytical …, 2020 - ACS Publications
Programmed cell death-1 (PD-1), an antigen co-receptor on cell surfaces, is one of the
conspicuous immune checkpoints. Nivolumab, a monoclonal antibody therapeutic approved by …

Exploration of pericyclic reaction transition structures by quantum mechanical methods: competing concerted and stepwise mechanisms

KN Houk, BR Beno, M Nendel, K Black, HY Yoo… - Journal of Molecular …, 1997 - Elsevier
Density functional theory and multiconfigurational SCF calculations have been applied to a
number of pericyclic reactions, including cycloadditions, electrocyclizations and sigmatropic …

Theoretical Studies of the Structure, Aromaticity, and Magnetic Properties of o‐Benzyne

…, R Warmuth, KN Houk, BR Beno - … Edition in English, 1997 - Wiley Online Library
Theoretical computations give new insights into the energetic, geometric, and magnetic
properties of highly reactive o‐benzyne. Comparisons with experimental NMR data for the …

Orthogonal mass spectrometry-based footprinting for epitope mapping and structural characterization: the IL-6 receptor upon binding of protein therapeutics

…, J Mo, RYC Huang, EG Deyanova, BR Beno… - Analytical …, 2017 - ACS Publications
Higher-order structure (HOS) is a crucial determinant for the biological functions and quality
attributes of protein therapeutics. Mass spectrometry (MS)-based protein footprinting …

An integrated approach for determining a protein–protein binding interface in solution and an evaluation of hydrogen–deuterium exchange kinetics for adjudicating …

MM Zhang, BR Beno, RYC Huang, J Adhikari… - Analytical …, 2019 - ACS Publications
We describe an integrated approach of using hydrogen–deuterium exchange mass spectrometry
(HDX-MS), chemical cross-linking mass spectrometry (XL-MS), and molecular docking …